Related Experiment Video

Updated: Dec 6, 2025

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.6K

Inflammatory Cytokines and Atherosclerotic Plaque Progression. Therapeutic Implications

Antonio V Sterpetti1,2

  • 1University of Rome Sapienza, Rome, Italy. antonio.sterpetti@uniroma1.it.

Current Atherosclerosis Reports
|October 7, 2020
PubMed

Insights

Personalized anti-inflammatory therapy can improve outcomes for cardiovascular disease by monitoring inflammatory cytokines. Tailoring medical treatment based on inflammatory mediators offers potential to alter atherosclerosis progression.

Area of Science:

  • Cardiovascular Medicine
  • Immunology

Background:

  • Inflammatory cytokines are key drivers of atherosclerotic plaque development.
  • Systemic inflammation influences clinical outcomes in cardiovascular disease prevention and treatment.

Purpose of the Study:

  • To review the rationale for personalized anti-inflammatory therapy in atherosclerosis.
  • To explore the use of inflammatory mediators in tailoring cardiovascular treatments.

Main Methods:

  • Literature review of studies on inflammation and atherosclerosis.
  • Analysis of current clinical practices and future therapeutic potential.

Main Results:

  • Systemic inflammatory parameters can guide clinical outcomes in primary and secondary prevention.
  • Therapy for stable and acute cardiovascular events can be personalized using inflammatory mediator levels.
  • Current treatment strategies for cardiovascular disease can be improved by incorporating inflammatory parameters alongside blood pressure and cholesterol.

Conclusions:

  • Personalized anti-inflammatory strategies hold significant potential for improving cardiovascular disease management.
  • Further understanding of inflammation-atherosclerosis mechanisms may lead to novel, targeted anti-inflammatory drugs.
Abstract

Keywords:
AtherosclerosisCytokinesGrowth factorsHemodynamic forcesInflammation

More Related Videos

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.6K
Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

10.4K

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
542
Inflammation01:38

Inflammation

Overview
60.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
221
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
244
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.4K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
718